[{"address1": "2051 Ringwood Avenue", "city": "San Jose", "state": "CA", "zip": "95131", "country": "United States", "phone": "408 457 3700", "website": "https://www.ranitherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-116 which is in discovery stage for the treatment of obesity; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mir A. Imran", "age": 67, "title": "Executive Chairman", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 40000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Talat  Imran", "age": 42, "title": "CEO & Director", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 105818, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Svai S. Sanford", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mir  Hashim", "age": 64, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alireza  Javadi", "title": "Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bella  Vazquez", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  McKinley M.B.A.", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Betsy  Gutierrez", "title": "Senior Vice President of Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Arvinder  Dhalla", "title": "Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.508, "open": 0.5057, "dayLow": 0.5, "dayHigh": 0.5189, "regularMarketPreviousClose": 0.508, "regularMarketOpen": 0.5057, "regularMarketDayLow": 0.5, "regularMarketDayHigh": 0.5189, "payoutRatio": 0.0, "beta": -0.0, "forwardPE": -0.49554458, "volume": 265988, "regularMarketVolume": 265988, "averageVolume": 440890, "averageVolume10days": 332530, "averageDailyVolume10Day": 332530, "bid": 0.354, "ask": 0.655, "bidSize": 2, "askSize": 2, "marketCap": 29431304, "fiftyTwoWeekLow": 0.462, "fiftyTwoWeekHigh": 4.37, "priceToSalesTrailing12Months": 24.526087, "fiftyDayAverage": 0.80418, "twoHundredDayAverage": 1.59477, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 24324912, "profitMargins": 0.0, "floatShares": 20910239, "sharesOutstanding": 33570300, "sharesShort": 3112578, "sharesShortPriorMonth": 2345512, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.092700005, "heldPercentInsiders": 0.27793, "heldPercentInstitutions": 0.1015, "shortRatio": 3.82, "shortPercentOfFloat": 0.131, "impliedSharesOutstanding": 58803800, "bookValue": -0.091, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -29799000, "trailingEps": -0.98, "forwardEps": -1.01, "enterpriseToRevenue": 20.271, "enterpriseToEbitda": -0.523, "52WeekChange": -0.8783455, "SandP52WeekChange": 0.09544468, "quoteType": "EQUITY", "currentPrice": 0.5005, "targetHighPrice": 12.0, "targetLowPrice": 4.0, "targetMeanPrice": 7.8, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 15853000, "totalCashPerShare": 0.472, "ebitda": -46548000, "totalDebt": 25669000, "quickRatio": 0.817, "currentRatio": 0.883, "totalRevenue": 1200000, "revenuePerShare": 0.04, "returnOnAssets": -0.76605004, "returnOnEquity": -11.87524, "grossProfits": 1200000, "freeCashflow": -15498125, "operatingCashflow": -34243000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -69.84302, "financialCurrency": "USD", "symbol": "RANI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Rani Therapeutics Holdings, Inc", "marketState": "CLOSED", "regularMarketChangePercent": -1.47638, "regularMarketPrice": 0.5005, "twoHundredDayAverageChange": -1.09427, "twoHundredDayAverageChangePercent": -0.68616164, "priceToBook": -5.5000005, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "cryptoTradeable": false, "exchange": "NGM", "messageBoardId": "finmb_242425883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Rani Therapeutics Holdings, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": 5.67433, "postMarketPrice": 0.5289, "postMarketChange": 0.0284, "regularMarketChange": -0.00749999, "regularMarketDayRange": "0.5 - 0.5189", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 440890, "fiftyTwoWeekLowChange": 0.03850001, "fiftyTwoWeekLowChangePercent": 0.08333336, "fiftyTwoWeekRange": "0.462 - 4.37", "fiftyTwoWeekHighChange": -3.8695, "fiftyTwoWeekHighChangePercent": -0.88546914, "fiftyTwoWeekChangePercent": -87.83455, "earningsTimestamp": 1747166700, "earningsTimestampStart": 1747166700, "earningsTimestampEnd": 1747166700, "earningsCallTimestampStart": 1743453000, "earningsCallTimestampEnd": 1743453000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.98, "epsForward": -1.01, "epsCurrentYear": -0.575, "priceEpsCurrentYear": -0.8704348, "fiftyDayAverageChange": -0.30368, "fiftyDayAverageChangePercent": -0.3776269, "corporateActions": [], "postMarketTime": 1750462085, "regularMarketTime": 1750449600, "displayName": "Rani Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-06-21"}]